Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic agent frequently used in elective surgery to reduce blood loss. We recently found it also acts as a potent immune-modulator in patients undergoing cardiac surgery. METHODS: Patients undergoing lower limb surgery were enrolled into the “Tranexa...

Descripción completa

Detalles Bibliográficos
Autores principales: Draxler, Dominik F., Hanafi, Gryselda, Zahra, Saffanah, McCutcheon, Fiona, Ho, Heidi, Keragala, Charithani B., Liu, Zikou, Daly, David, Painter, Thomas, Wallace, Sophia, Plebanski, Magdalena, Myles, Paul S., Medcalf, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996554/
https://www.ncbi.nlm.nih.gov/pubmed/35410340
http://dx.doi.org/10.1186/s12959-022-00373-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996554/
https://www.ncbi.nlm.nih.gov/pubmed/35410340
http://dx.doi.org/10.1186/s12959-022-00373-3

Ejemplares similares